LEAH MAGNUSON: Open Payments
NPI 1700322245 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 70 payments from 8 companies in 2025. Trend: 2023 $1,121 · 2024 $975 · 2025 $1,192
Food & beverage: $1,192
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 26 | $499 |
| Neurocrine BioSciences, Inc. | 26 | $330 |
| Alkermes, Inc. | 8 | $143 |
| Teva Pharmaceuticals USA, Inc. | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| ABBVIE INC. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: COBENFY, INGREZZA, ARISTADA, AUSTEDO XR, UZEDY, ABILIFY MAINTENA, CAPLYTA, VRAYLAR.
Industry payments across MI — which companies pay providers there.
